Each tablet contains Cefpodoxime Proxetil 200 mg and Ofloxacin 200 mg.

Microcef O Tablets combine Cefpodoxime Proxetil, a third-generation cephalosporin, with Ofloxacin, a broad-spectrum fluoroquinolone antibiotic, to provide enhanced antibacterial coverage against a wide range of Gram-positive and Gram-negative pathogens. The dual mechanism of action ensures effective bacterial eradication and makes Microcef O a suitable choice for the treatment of respiratory and urinary tract infections caused by susceptible organisms.q

Microcef O Tablets are indicated for the treatment of lower respiratory tract infections, upper respiratory tract infections, and urinary tract infections (UTIs) caused by susceptible bacterial pathogens.

Cefpodoxime is a bactericidal cephalosporin antibiotic that inhibits bacterial cell wall synthesis, resulting in bacterial cell death. It remains active in the presence of several β-lactamases produced by Gram-positive and Gram-negative bacteria. Ofloxacin is a fluoroquinolone antibacterial agent that inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, enzymes essential for DNA replication, repair, and cell division. The combination provides complementary antibacterial activity against a broad spectrum of susceptible organisms.

The recommended dosage is one tablet daily or as directed by the treating physician. The duration of therapy should be determined based on the type and severity of the infection and the patient's clinical response.

Microcef O Tablets are contraindicated in patients with known hypersensitivity to Cefpodoxime, Ofloxacin, cephalosporins, fluoroquinolones, or any component of the formulation.